In mouse models, ghrelin inhibits HCC progression by reducing TG content and cytokines such as TNF-α as well as IL-6, and alleviates lipotoxicity by stimulating autophagy and inhibiting nuclear factor-κB (NF-ĸB) pathway (40). Here, TNF is linked to hepatocellular carcinoma.